During 2020, SGD Pharma continued its daily operations and even improved performance in all plants, strengthened clients’ trust and gained market shares, accelerated R&D capabilities, and recruited and improved training efforts. Our plants in Asia and Europe are all subject to the highest level of safety measures to ensure the health and safety of employees while continuing manufacturing operations.
To manufacture and ship vaccines globally requires highly managed logistics and access to continuous and secured supply of ancillary materials to ensure vaccine distribution does not face any bottlenecks. As a glass primary packaging company, we are working tirelessly to help guarantee this access for global COVID-19 immunization campaigns.
- About us
- News
- Careers
- Products & Innovations
- Ampoules
- Vials Type I
- Injectable vials
- Infusions
- Oral
- Nasal
- Healthcare
- Beauty & Care
- SGD Pharma Plus
- Media center
- Contact us